ENDRA Life Sciences Inc (NDRA)
0.105
-0.01
(-5.06%)
USD |
NASDAQ |
Jun 25, 16:00
0.1013
0.00 (0.00%)
After-Hours: 20:00
ENDRA Life Sciences Research and Development Expense (Quarterly): 1.042M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.042M |
| December 31, 2023 | 0.5794M |
| September 30, 2023 | 1.633M |
| June 30, 2023 | 1.400M |
| March 31, 2023 | 1.391M |
| December 31, 2022 | 1.663M |
| September 30, 2022 | 1.830M |
| June 30, 2022 | 1.848M |
| March 31, 2022 | 1.213M |
| December 31, 2021 | 1.423M |
| September 30, 2021 | 1.173M |
| June 30, 2021 | 1.745M |
| March 31, 2021 | 1.142M |
| December 31, 2020 | 1.143M |
| September 30, 2020 | 1.769M |
| June 30, 2020 | 1.487M |
| March 31, 2020 | 1.518M |
| December 31, 2019 | 2.028M |
| Date | Value |
|---|---|
| September 30, 2019 | 1.468M |
| June 30, 2019 | 1.305M |
| March 31, 2019 | 1.774M |
| December 31, 2018 | 1.051M |
| September 30, 2018 | 1.163M |
| June 30, 2018 | 0.8398M |
| March 31, 2018 | 1.669M |
| December 31, 2017 | 1.36M |
| September 30, 2017 | 0.3005M |
| June 30, 2017 | 0.1747M |
| March 31, 2017 | 0.0958M |
| December 31, 2016 | 0.159M |
| September 30, 2016 | 0.1375M |
| June 30, 2016 | 0.1036M |
| March 31, 2016 | 0.0952M |
| December 31, 2015 | 0.2707M |
| September 30, 2015 | 0.265M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.5794M
Minimum
Dec 2023
2.028M
Maximum
Dec 2019
1.440M
Average
1.446M
Median
Research and Development Expense (Quarterly) Benchmarks
| Cutera Inc | 5.001M |
| Dynatronics Corp | -- |
| Stereotaxis Inc | 2.243M |
| Electromed Inc | 0.167M |
| Myomo Inc | 0.9562M |